or
forgot password

    • cancer clinical trials in wyoming, MI

    • PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Metro Health Cancer Care
    Wyoming, Michigan 49519
    Breast Cancer
    Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
    Metro Health Cancer Care
    Wyoming, Michigan 49519
    Multiple Myeloma
    First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
    Metro Health Cancer Care
    Wyoming, Michigan 49519
    Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Metro Health Cancer Center
    Wyoming, Michigan 49519
    Non Small Cell Lung Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Gastroenterology Associates of Western Michigan, P.L.C.
    Wyoming, Michigan 49519
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Gastroenterology Associates of Western Michigan, P.L.C.
    Wyoming, Michigan 49519
    Ulcerative Colitis